![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Alex Zhavoronkov, PhD - Insilico Medicine
Saturday 26 November 2022, 13:00-14:00
Using AI to Discover Dual-purpose Therapeutics Targeting Aging and Disease at the same time
- đ¤ Speaker: Alex Zhavoronkov, PhD - Insilico Medicine
- đ Date & Time: Saturday 26 November 2022, 13:00 - 14:00
- đ Venue: Virtual Talk (Zoom)
Abstract
Insilico Medicine is a leader in next generation artificial intelligence technologies for drug discovery and biomarker development. They have raised over $415 million in multiple rounds, nominated 8 preclinical candidates and entered human clinical trials with an AI-discovered and AI-designed antifibrotic, and recently struck a deal with Sanofi worth up to $1.2 billion. Alex is an adjunct professor of artificial intelligence at the Buck Institute for Research on Aging and has published over 160 peer-reviewed academic publications and two books since 2014, and has pledged his commitment to the Longevity Field.
https://us02web.zoom.us/meeting/register/tZAqcuioqTMqGtZhgBH5SVpxOy8nbL910ILV
Series This talk is part of the Cambridge University Longevity Society 2023-2024 Series series.
Included in Lists
- Biology
- Cambridge Neuroscience Seminars
- Cambridge talks
- Cambridge University Longevity Society 2023-2024 Series
- Chris Davis' list
- dh539
- dh539
- Featured lists
- Life Science
- Life Sciences
- Neuroscience
- Neuroscience Seminars
- Neuroscience Seminars
- Stem Cells & Regenerative Medicine
- Virtual Talk (Zoom)
Note: Ex-directory lists are not shown.